Stock comparison
Alignment Healthcare
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALHC
Alignment Healthcare
Market cap
$3.38B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALHC | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 34F | 72B | LLY |
| Benjamin Graham | 68D | 86A | LLY |
| Philip Fisher | 46D | 86A | LLY |
| Peter Lynch | 66B | 74B | LLY |
| Joel Greenblatt | 43D | 78C | LLY |
| Charlie Munger | 36D | 85A | LLY |
| Terry Smith | 33F | 77C | LLY |
Side-by-side metrics
| Metric | ALHC | LLY |
|---|---|---|
| Market cap | $3.38B | $1T |
| P/E (TTM) | 186.4x | 36.6x |
| EV/EBIT | 178.7x | 34.1x |
| ROIC (TTM) | 5.88% | 32.06% |
| Gross margin | 12.38% | 83.51% |
| Net margin | 0.47% | 34.98% |
| Revenue CAGR 5y | 35.6% | 23.17% |
| EPS CAGR 5y | - | 40.81% |
| Debt / Equity | 1.6x | 1.4x |
| Dividend yield | 0.0% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALHC leads on
- Revenue CAGR 5y35.6%vs 23.17%+35%
LLY leads on
- Dividend yield0.62%vs 0.0%+100%
- Market cap$1Tvs $3.38B+100%
- Net margin34.98%vs 0.47%+99%
- Gross margin83.51%vs 12.38%+85%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.